AndreaBozzo/ceres-open-data-index huggingface dataset:
National Survey on Drug Use and Health (NSDUH-2012)

<p>The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2012 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.</p>
Compound 525278: Cholestenyl butyrate

Chemical compound data from PubChem database. IUPAC Name: [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] butanoate. Molecular Formula: C31H52O2. Molecular Weight: 456.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528874: 7-Chloro-2-(4-chlorophenyl)-8-methyl-4-quinolinecarboxylic acid

Chemical compound data from PubChem database. IUPAC Name: [4-[3-oxo-2-(2,2,3,3,3-pentafluoropropanoylamino)-3-(2,2,2-trifluoroethoxy)propyl]-2-(2,2,3,3,3-pentafluoropropanoyloxy)phenyl] 2,2,3,3,3-pentafluoropropanoate. Molecular Formula: C20H9F18NO7. Molecular Weight: 717.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
CDC Wonder Vaccine Adverse Event Reporting System

<p>The Vaccine Adverse Event Reporting System (VAERS) online database on CDC WONDER provides counts and percentages of adverse event case reports after vaccination, received since January 1990 through last month. Data are available by symptom, vaccine product, manufacturer, onset interval, outcome category, year and month vaccinated, year and month reported, age, sex and state / territory. The Vaccine Adverse Event Reporting System is a cooperative program for vaccine safety of the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a post-marketing safety surveillance program, collecting information about adverse events (possible side effects) that occur after the administration of US licensed vaccines. Data are from the US Department of Health and Human Services (DHHS), Public Health Service (PHS), Food and Drug Administration (FDA)/ Centers for Disease Control (CDC), Vaccine Adverse Event Reporting System (VAERS).</p>
Boston: Drug-Related Emergency Department Visits, 2004-2011 - Illicits (excluding alcohol)

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving illicit drugs for the Boston metropolitan area, covering 2004-2011. These visits involve the use of drugs that have limited or no therapeutic value and are generally illegal if taken without a prescription. It also includes visits involving the inhalation of substances for their psychoactive properties (e.g., sniffing model airplane glue).
Compound 529294: 4-Octyne, 2,7-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 2,7-dimethyloct-4-yne. Molecular Formula: C10H18. Molecular Weight: 138.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526464: Methyl Undecafluorohexanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoate. Molecular Formula: C7H3F11O2. Molecular Weight: 328.08. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2004 National Nursing Assistant Survey - Restricted Dataset

The 2004 National Nursing Home Survey (NNHS), conducted between August and December of 2004, was reintroduced into the field after a five-year break, during which time the survey was redesigned and expanded to collect many new data items. The 2004 NNHS included a supplemental survey of nursing assistants employed by nursing homes, the National Nursing Assistant Survey (NNAS), which was sponsored by the Office of the Assistant Secretary for Planning and Evaluation (APSE). Nursing assistants were considered eligible to participate in the survey if they 1) provided assistance with activities of daily living (ADLs); 2) were paid to provide those services; 3) were certified (or in the process of certification) to provide Medicare/Medicaid reimbursable services; 4) worked at least 16 hours per week; and 5) were employees of the nursing home and not contract employees. A sample of up to eight nursing assistants was selected from about half of the nursing home sample at the time of the facility interview. The NNAS was administered after the nursing home visit, using a computer-assisted telephone interview (CATI) system.
Patent AT-E400615-T1: [Translated] EMULSION COATING MIXTURE FOR ASPHALTING A ROAD AND ROAD ASPHALT PRODUCED THEREFROM

An emulsion surfacing mix intended for paving a road, and a road surfacing made thereof, which emulsion surfacing mix comprises bitumen, aggregate, water and breaking-controlling agent comprising silicon. In a preferred embodiment, the breaking-time-controlling material is granulated blast-furnace slag or slag powder ground out of it, which materials also function as a binding agent for the emulsion mix.
Instructions to update the SAMHSA SMI and SED Estimates URS Table 1: Number of Adults with Serious Mental Illness, age 18 and older, by State, 2016

These instructions explain how to update the 2016 Substance Abuse and Mental Health Services Administration (SAMHSA) Serious Mental Illness (SMI) and Serious Emotional Disturbances (SED) estimates. This includes obtaining the latest population data by state from the U.S. Census Bureau as well as the calculations and methodology necessary to create updated estimates.
Patent AT-E400390-T1: [Translated] CLAMPING TOOL, ESPECIALLY SOLDERING PLIERS, WITH A COMPENSATION SYSTEM

A clamping tool comprises first and second clamping components (18, 20) able to be displaced relative to each other by a drive device made up of: (A) a screw (10), able to rotate around an axis (XX) in opposing directions by means of a motor (M), with a nut (12) co-operating with the screw and which can be rotated in the direction of the axis of the screw, the screw being coupled in translation to the first clamping component; (B) a first guidance mechanism (34L) defining linear guidance parallel to the axis of the screw to rotationally block the nut in a first phase of nut displacement; (C) a second guidance mechanism (34H) defining helicoidal guidance extending according to the axis of the screw and which has an inverted thread in relation to that of the screw to enable the nut to rotate in the same direction as the screw in a second nut displacement phase; (D) in addition a compensation system (46) is arranged between the first clamping component and a mobile suppor! t (14) coupled to the nut to re-initialise the position of the first clamping component in relation to the second clamping component, such that the first and second displacement phases remain synchronous with the phases which are required to optimise displacement of the first clamping component.
Patent AT-E400141-T1: [Translated] UNIVERSAL METHOD AND DEVICE FOR PORTABLE ADVERTISING OCCASIONS

A system is described for deriving benefits from the reception and processing of auxiliary data by a hand-held device 12, such as a smart card, personal digital assistant ("PDA"), or mobile phone. Aiming light 24 and/or audio transducer 34 alert the user of hand-held device 12 that auxiliary data is being received. The auxiliary data is then utilized by hand-held device 12. The user receives benefits such as promotional opportunities resulting from the reception of the auxiliary data. Such opportunities are expressed on visual display 20, which may include a series of lights 20a, 20b, 20c, and/or 20d, or an LCD 44. The lights and LCD provide promotional opportunities which may be redeemable and conventional stores or via the Internet. Hand-held devices 12 are outfitted with a PCMCIA interface 70 or wireless Internet access to obtain such promotional activities on the Internet. Hand-held device 12 may have housing 14 in various shapes to promote various promotional opportunities. On front surface 16 of the hand-held device may have indication of a sponsor 17.
Deer Tick Surveillance: Adults (Oct to Dec) Powassan Virus Only: Beginning 2009

This dataset provides the results from collecting and testing adult deer ticks, also known as blacklegged ticks, or by their scientific name Ixodes scapularis. Collection and testing take place across New York State (excluding New York City) from October to December, when adult deer ticks are most commonly seen. 

Adult deer ticks are tested in “pools”, or groups of up to ten adult ticks per pool, for the Powassan virus, also known as Deer tick virus. These data should simply be used to educate people that there is a risk of coming in contact with ticks and tick-borne diseases.

These data only provide adult tick minimum infection rates at a precise location and at a point in time. Both measures, tick population density and minimum infection percentages, can vary greatly within a very small area and within a county. These data should not be used to broadly predict disease risk for a county.

Further below on this page you can find links to tick prevention tips, a video on how to safely remove a tick, and more datasets with tick testing results. Interactive charts and maps provide an easier way to view the data.
Compound 529608: Cyclotetrasilane, octaethyl-

Chemical compound data from PubChem database. IUPAC Name: 1,1,2,2,3,3,4,4-octaethyltetrasiletane. Molecular Formula: C16H40Si4. Molecular Weight: 344.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528761: 4H-Indene, 5,7a-dihydro-1,4,4,7a-tetramethyl-

Chemical compound data from PubChem database. IUPAC Name: 1,4,4,7a-tetramethyl-5H-indene. Molecular Formula: C13H18. Molecular Weight: 174.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529398: 2-Methylthiophene-3-carbaldehyde

Chemical compound data from PubChem database. IUPAC Name: 2-methylthiophene-3-carbaldehyde. Molecular Formula: C6H6OS. Molecular Weight: 126.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Analysis of stress- and host cell-induced expression of the

Background
          The gene encoding the inorganic pyrophosphatase (PPase) of the intracellular pathogen Legionella pneumophila is induced during intracellular infection, but is constitutively expressed in Eschericia coli. The causative agent of tuberculosis, Mycobacterium tuberculosis, contains a well conserved copy of PPase. We sought to determine if expression of the M. tuberculosis PPase is regulated by the intracellular environment.
        
        
          Results
          A strain of Mycobacterium bovis bacille Calmette-Guérin (BCG) was constructed in which the Aequoria victoria green fluorescent protein (GFP) is controlled by the promoter of the M. tuberculosis ppa gene. After prolonged exposure of the recombinant BCG strain within murine bone-marrow-derived macrophages, there was no observed increased activity of the ppa promoter. Furthermore, there was no change in promoter activity after exposure to various stress stimuli such as reduced pH, osmotic shock, nutrient limitation or oxidative stress.
        
        
          Conclusions
          These results suggest that macrophage induction of ppa is not a general phenomenon among intracellular pathogens.
TheG-308Avariant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution

Tumor Necrosis Factor-α (TNF-α) has been implicated in the pathogenesis of insulin resistance and obesity. The increased expression of TNF-α in adipose tissue has been shown to induce insulin resistance, and a polymorphism at position -308 in the promoter region ofTNF-αhas been shown to increase transcription of the gene in adipocytes. Aim of this study is to investigate the role of theG-308A TNFαvariant in obesity and to study the possible influence of this mutation on body fat distribution and on measures of obesity (including Fat Free Mass, Fat Mass, basal metabolic rate), insulin resistance (measured as HOMAIR), and lipid abnormalities. TheG-308A TNFαpolymorphism has been studied in 115 patients with obesity (mean BMI 33.9 ± 0.5) and in 79 normal lean subjects (mean BMI 24.3 ± 0.3).
Compound 530148: Benzenepropanoic acid, 3-hydroxy-4-methoxy, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3-(4-methoxy-3-trimethylsilyloxyphenyl)propanoate. Molecular Formula: C16H28O4Si2. Molecular Weight: 340.56. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525803: N-(4-Methylphenyl)-N'-(4-chlorophenyl)formamidine

Chemical compound data from PubChem database. IUPAC Name: N-(4-chlorophenyl)-N'-(4-methylphenyl)methanimidamide. Molecular Formula: C14H13ClN2. Molecular Weight: 244.72. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
TANF Financial Data

The TANF Financial Data tables compile Federal TANF and State MOE expenditures for reported by states by fiscal year.

<b>Units of Response: </b>States

<b>Type of Data: </b>Financial

<b>Tribal Data: </b>No

<b>Periodicity: </b>Annual

<b>Demographic Indicators: </b>Not Applicable

<b>SORN: </b>Not Applicable

<b>Data Use Agreement: </b>https://www.icpsr.umich.edu/rpxlogin

<b>Data Use Agreement Location: </b>Unavailable

<b>Granularity: </b>State

<b>Spatial: </b>United States

<b>Geocoding: </b>State
CDC.gov CleanSlate and Relaunch URL Mappings

CDC is planning a major relaunch of CDC.gov on May 15th, followed by subsequent monthly batches of sites restructuring their CDC.gov content into the fall of 2024.
 
Because this restructuring includes merged or changed content, CDC will be updating all URLs to a new standard naming structure. About 70% of these updates will occur during the May 15th launch, but another 30% of our content and URLs will be restructured on a rolling schedule. 
 
This data set contains the mapping information from old URLs to new URLs. Before May 15th, 2024, this dataset will only include one row of data to preview the fields in the dataset. After May 15th it will contain all content URLs that changed as part of the relaunch of CDC.gov. After launch, we will continue to add additional mappings typically around the 15th of each month for any for sites updated in each monthly batch.
4,4’-Methylene Diphenyl Diisocyanate Exposure Induces Expression of Alternatively Activated Macrophage-Associated Markers and Chemokines Partially Through Krüppel-Like Factor 4 Mediated Signaling in Macrophages

Exposure to 4,4’-methylene diphenyl diisocyanate (MDI), the most widely used monomeric diisocyanate, in the occupational setting may lead to the development of occupational asthma (OA). Currently, the underlying molecular mechanism(s) by which MDI induces OA remain an active area of research. Alveolar macrophage dysfunctions play important roles in asthma pathogenesis. Upon exposure to outside stimuli, macrophages are polarized into either classically activated (M1) or alternatively activated (M2) phenotypes. Macrophage polarization is associated with asthma development where M2 macrophage populations are usually pronounced in lungs of asthmatic patients. Recent in vivo studies demonstrated that M2 macrophage associated markers and chemokines were induced by MDI exposure, indicating that MDI may induce M2 macrophage polarization; however, the underling molecular mechanism(s) by which MDI causes induction of M2 associated markers and chemokines is unclear. M2 macrophage polarization can be regulated by activation of several M2 associated transcription factors; however, whether MDI exposure regulates these transcription factors is unknown. We hypothesize that MDI exposure induces M2 macrophage associate markers and chemokines through upregulation of M2 macrophage-associated transcription factors in macrophages. The first aim of this study is to verify whether MDI-exposure can induce M2 macrophage-associated markers and chemokine expression that were observed in previous studies and to identify candidate M2 macrophage-associated transcription factors in response to MDI exposure that may account for the M2 macrophage polarization. After identification of the candidate transcription factor(s) that can be regulated by MDI-exposure, we investigate the roles of the candidate transcription factor in regulation of these candidate M2 macrophage associate markers and chemokines in relation to the exposure to MDI.
Hawaii: 2011-2012 NSDUH

This report presents Hawaii\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 528746: 1,2,4,5-Tetrathiane, 3-methyl-6-pentyl, #1

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-6-pentyl-1,2,4,5-tetrathiane. Molecular Formula: C8H16S4. Molecular Weight: 240.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Measuring access to effective care among elderly medicare enrollees in managed and fee-for-service care: a retrospective cohort study

Background
          Our aim was to compare access to effective care among elderly Medicare patients in a Staff Model and Group Model HMO and in Fee-for-Service (FFS) care.
        
        
          Methods
          We used a retrospective cohort study design, using claims and automated medical record data to compare achievement on quality indicators for elderly Medicare recipients. Secondary data were collected from 1) HMO data sets and 2) Medicare claims files for the time period 1994–95. All subjects were Medicare enrollees in a defined area of New England: those enrolled in two divisions of a managed care plan with different physician payment arrangements: a staff model, and a group model; and the Medicare FFS population. We abstracted information on indicators covering several domains: preventive, diagnosis-specific, and chronic disease care.
        
        
          Results
          On the indicators we created and tested, access in the single managed care plan under study was comparable to or better than FFS care in the same geographic region. Percent of Medicare recipients with breast cancer screening was 36 percentage points higher in the staff model versus FFS (95% confidence interval 34–38 percentage points). Follow up after hospitalization for myocardial infarction was 20 percentage points higher in the group model than in FFS (95% confidence interval 14–26 percentage points).
        
        
          Conclusion
          According to indicators developed for use in both claims and automated medical record data, access to care for elderly Medicare beneficiaries in one large managed care organization was as good as or better than that in FFS care in the same geographic area.
U.S. Department of Health and Human Services Office of Inspector General Advisory Opinion List

<p>This OIG website contains a list of recently issued advisory opinions and a link to archives of previously issued advisory opinions.  In accordance with section 1128D (b) (5) (A) (v) of the Social Security Act and 42 CFR 1008.47 of the Office of Inspector General's (OIG) regulations, advisory opinions issued by the OIG are made available to the general public through this OIG website. One purpose of the advisory opinion process is to provide meaningful advice on the application of the anti-kickback statute and other OIG sanction statutes in specific factual situations. Please note, however, that advisory opinions are binding and may legally be relied upon only by the requestor. Because each opinion will apply legal standards to a set of facts involving certain known persons who provide specific statements about key factual issues, no third parties are bound nor may they legally rely on these advisory opinions.</p>